Carbazole-containing arylcarboxamides as BACE1 inhibitors

被引：25

作者：

Bertini, Simone ^{[1
]}

Asso, Valentina ^{[1
]}

Ghilardi, Elisa ^{[1
]}

Granchi, Carlotta ^{[1
]}

Manera, Clementina ^{[1
]}

Minutolo, Filippo ^{[1
]}

Saccomanni, Giuseppe ^{[1
]}

Bortolato, Andrea ^{[2
]}

Mason, Jonathan ^{[2
,4
]}

Moro, Stefano ^{[3
]}

Macchia, Marco ^{[1
]}

机构：

[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy

[2] Heptares Therapeut Ltd, Welwyn Garden City AL7 RAX, Herts, England

[3] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy

[4] Lundbeck AS, DK-2500 Copenhagen, Denmark

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 22期

关键词：

Alzheimer; BACE1; Carbazole; Molecular docking; Flap; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; DESIGN; MODEL; SITE; MATURATION; PREDICTION; DOCKING;

D O I：

10.1016/j.bmcl.2011.09.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

beta-Secretase (BACE1) is widely recognized as a prime drug target for the treatment of Alzheimer's disease (AD). In this Letter, we report the synthesis and the BACE1 inhibitory activity of novel, variously substituted N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-arylcarboxamides. The best results have been obtained with the introduction of a 4-OMe substituent (IC50 = 3.8 mu M) or a 3,4-dichloro substituent (IC50 = 2.5 mu M) in the amidic aromatic ring. The blood-brain barrier penetration predictions resulted to be promising for this type of compounds. To better understand the structure-activity relationships (SAR) of the new derivatives, a docking study procedure has been applied exploiting different conformational and ionic states of BACE1. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6657 / 6661

页数：5

共 50 条

[21] Structure-Based β-Secretase (BACE1) Inhibitors
Polgar, Timea
Keseru, Gyoergy M.
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (20) : 3373 - 3379
[22] EXITONE MIGRATION IN CARBAZOLE-CONTAINING SEMICONDUCTORS
NACHODKIN, TN
PEREPELITSA, VK
ZHURNAL NAUCHNOI I PRIKLADNOI FOTOGRAFII, 1990, 35 (01): : 57 - 62
[23] Synthesis of new carbazole-containing fullerenopyrrolidines
V. P. Gubskaya
E. V. Ovechkina
V. V. Yanilkin
V. I. Morozov
N. V. Nastapova
V. V. Zverev
N. M. Azancheev
I. A. Nuretdinov
Russian Chemical Bulletin, 2005, 54 : 334 - 341
[24] Design and synthesis of cyclic acylguanidines as BACE1 inhibitors
Liu, Jia-Kuo
Gu, Wei
Cheng, Xiao-Rui
Cheng, Jun-Ping
Zhou, Wen-Xia
Nie, Ai-Hua
CHINESE CHEMICAL LETTERS, 2015, 26 (10) : 1327 - 1330
[25] 2-Iminohydantoins as potential BACE1 inhibitors
Sun, Zhong-Yue
Zhu, Zhaoning
Ye, Yuanzan
McKittrick, Brian
Stamford, Andrew
Wyss, Daniel
Wang, Yu-Sen
Senior, Mary
Voigt, Johannes
Strickland, Corey
Madison, Vincent
Kennedy, Matthew
Kuvelkar, Reshma
Chen, Xia
Parker, Eric
Hunter, John
Czarniecki, Michael
Greenlee, William
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[26] Pyridinyl aminohydantoins as small molecule BACE1 inhibitors
Zhou, Ping
Li, Yanfang
Fan, Yi
Wang, Zheng
Chopra, Rajiv
Olland, Andrea
Hu, Yun
Magolda, Ronald L.
Pangalos, Menelas
Reinhart, Peter H.
Turner, M. James
Bard, Jonathan
Malamas, Michael S.
Robichaud, Albert J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2326 - 2329
[27] Development of BACE1 inhibitors for Alzheimer's disease
Guo, Tao
Hobbs, Doug W.
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (15) : 1811 - 1829
[28] Synthetic Strategies of Nonpeptidic β-Secretase (BACE1) Inhibitors
La Regina, Giuseppe
Piscitelli, Francesco
Silvestri, Romano
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2009, 46 (01) : 10 - 17
[29] β-Secretase (BACE1) inhibitors from Sanguisorbae Radix
Lee, HJ
Seong, YH
Bae, KH
Kwon, SH
Kwak, HM
Nho, SK
Kim, KA
Hur, JM
Lee, KB
Kang, YH
Song, KS
ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (07) : 799 - 803
[30] Phosphino peptides as inhibitors of human β-secretase (BACE1)
Manzenrieder, F.
Huber, T.
Frank, A.
Dorner-Ciossek, C.
Kessler, H.
JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 166 - 166

← 1 2 3 4 5 →